Neostigmine used in treatment of myasthenia gravis acts by:: (A) Increasing the number of receptors for acetylcholine, (B) Increasing synthesis of acetylcholine, (C) Decreasing breakdown of acetylcholine, (D) Increasing actylcholine degradation
Answer is C. None